Latest Breaking News On - Colin kellaher - Page 1 : comparemela.com

Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma

By Colin Kellaher Bristol Myers Squibb has won U.S. Food and Drug Administration expanded approval of its CAR-T cell therapy Breyanzi for adults with relapsed or refractory follicular lymphoma.

Inflation Cools as Core Prices Post Smallest Increase Since 2021

Inflation Cools as Core Prices Post Smallest Increase Since 2021 By Vicky Ge Huang U.S. inflation moderated slightly in April, with a key measure of price pressures slowing to its lowest level. -May 16, 2024 at 07:18 am EDT - MarketScreener

Eli Lilly Says Once-Weekly Insulin Meets Key Goal in Two Studies

By Colin Kellaher Eli Lilly on Thursday said a pair of late-stage studies of its proposed once-weekly insulin efsitora alfa met their primary endpoints. The Indianapolis drugmaker said.

Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio

By Colin Kellaher Johnson & Johnson has agreed to buy privately-held biotechnology company Proteologix for an initial $850 million in cash in a deal that bolsters the healthcare giant s.

Eli Lilly Ethics/Compliance Chief Alonzo Weems to Retire